Invitae

Traded on the St. Petersburg Stock Exchange
Invitae is a company specializing in genetic diagnosis and its implementation in medical practice to improve the quality of medical care. Invitae integrates the world's genetic tests into a single service with higher quality, faster lead times and lower cost than most modern single-genome diagnostic tests. The company's headquarters is located in San Francisco, California, USA.
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Invitae balance sheet

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Invitae cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Invitae multipliers

Report period2017 2018 2019 2020 2021 2022
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Invitae profitability

Report period2017 2018 2019 2020 2021 2022
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Invitae assets
Invitae cash flows
Invitae news
04.05.2022
Invitae's GAAP loss for the 3 months of 2022 was $181.859 million, up 66.1% from $109.492 million in the prior year. Revenue increased 19.4% to $123.691 million from $103.621 million a year earlier.
Source: {source} pictogram ir.invitae.com
Pictogram next
25.02.2022
Invitae's GAAP loss for 2021 was $379.006 million, down 37.1% from $602.17 million in the prior year. Revenue increased 64.7% to $460.449 million from $279.598 million a year earlier.
Source: {source} pictogram ir.invitae.com
Pictogram next
09.11.2021
Invitae's GAAP loss for 9M 2021 was $173.882 million, down 2.2 times from $367.832 million in the prior year. Revenue increased 86.6% to $334.328 million from $179.167 million a year earlier.
Source: {source} pictogram ir.invitae.com
Pictogram next
07.09.2021
Invitae is acquiring Ciitizen, a platform that allows clinic patients to collect, store and share their medical data digitally. The deal is valued at $325 million and is expected to close this month.
Source: {source} pictogram ir.invitae.com
Pictogram next
All Invitae news
General information
Company nameInvitae
SectorHealth Care / Health Care Equipment & Services / Health Care Providers & Services / Health Care Services
Business address1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Mailing address1400 16TH STREET SAN FRANCISCO CA 94103
Websitewww.invitae.com
Information disclosurewww.sec.gov